350 related articles for article (PubMed ID: 32277967)
1. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
[TBL] [Abstract][Full Text] [Related]
2. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum amyloid A in patients with COVID-19.
Cheng L; Yang JZ; Bai WH; Li ZY; Sun LF; Yan JJ; Zhou CL; Tang BP
Infection; 2020 Oct; 48(5):715-722. PubMed ID: 32734556
[TBL] [Abstract][Full Text] [Related]
4. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.
Liu Q; Dai Y; Feng M; Wang X; Liang W; Yang F
J Clin Lab Anal; 2020 Oct; 34(10):e23527. PubMed ID: 32860278
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study.
Yu Y; Liu T; Shao L; Li X; He CK; Jamal M; Luo Y; Wang Y; Liu Y; Shang Y; Pan Y; Wang X; Zhou F
Virulence; 2020 Dec; 11(1):1569-1581. PubMed ID: 33172355
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
8. Association of viral load with serum biomakers among COVID-19 cases.
Shi F; Wu T; Zhu X; Ge Y; Zeng X; Chi Y; Du X; Zhu L; Zhu F; Zhu B; Cui L; Wu B
Virology; 2020 Jul; 546():122-126. PubMed ID: 32452410
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].
Liu C; Deng X; Pan Y; Ling Z; Zhang G; Wei G; Peng P; He X; Zhang F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):548-553. PubMed ID: 32576345
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
Xu J; Zhao F; Han M; Ma L; Zhang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
Li M; Dong Y; Wang H; Guo W; Zhou H; Zhang Z; Tian C; Du K; Zhu R; Wang L; Zhao L; Fan H; Luo S; Hu D
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1061-1067. PubMed ID: 32456948
[TBL] [Abstract][Full Text] [Related]
13. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
14. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
16. Dynamic changes in routine blood parameters of a severe COVID-19 case.
Lu G; Wang J
Clin Chim Acta; 2020 Sep; 508():98-102. PubMed ID: 32405079
[TBL] [Abstract][Full Text] [Related]
17. Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19.
Abbas AA; Alghamdi A; Mezghani S; Ben Ayed M; Alamori AM; Alghamdi GA; Bajhmom W; Wajeeh H; Almutairi SS; Radwan WM
J Immunol Res; 2022; 2022():6336556. PubMed ID: 36465717
[TBL] [Abstract][Full Text] [Related]
18. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
Li L; Chen C
Epidemiol Infect; 2020 Jul; 148():e164. PubMed ID: 32713370
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
20. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
